JAC Advance Access published online on June 24, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki217
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Centro de Engenharia Biológica, Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal
* To whom correspondence should be addressed. Objectives: To quantitatively compare the antibiotic susceptibility of biofilms formed by the coagulase-negative staphylococci (CoNS) Staphylococcus epidermidis and Staphylococcus haemolyticus with the susceptibility of planktonic cultures. Methods: Several CoNS strains were grown planktonically or as biofilms to determine the effect of the mode of growth on the level of susceptibility to antibiotics with different mechanisms of action. The utility of a new, rapid colorimetric method that is based on the reduction of a tetrazolium salt (XTT) to measure cell viability was tested by comparison with standard bacterial enumeration techniques. A 6 h kinetic study was performed using dicloxacillin, cefazolin, vancomycin, tetracycline and rifampicin at the peak serum concentration of each antibiotic. Results: In planktonic cells, inhibitors of cell wall synthesis were highly effective over a 3 h period. Biofilms were much less susceptible than planktonic cultures to all antibiotics tested, particularly inhibitors of cell wall synthesis. The susceptibility to inhibitors of protein and RNA synthesis was affected by the biofilm phenotype to a lesser degree. Standard bacterial enumeration techniques and the XTT method produced equivalent results both in biofilms and planktonic assays. Conclusions: This study provides a more accurate comparison between the antibiotic susceptibilities of planktonic versus biofilm populations, because the cell densities in the two populations were similar and because we measured the concentration required to inhibit bacterial metabolism rather than to eradicate the entire bacterial population. While the biofilm phenotype is highly resistant to antibiotics that target cell wall synthesis, it is fairly susceptible to antibiotics that target RNA and protein synthesis.
Received February 11, 2005
Revised May 5, 2005
Accepted May 31, 2005
Original article
Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry
2 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Joana Azeredo, E-mail: jazeredo{at}deb.uminho.pt
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Nuryastuti, H. C. van der Mei, H. J. Busscher, S. Iravati, A. T. Aman, and B. P. Krom Effect of Cinnamon Oil on icaA Expression and Biofilm Formation by Staphylococcus epidermidis Appl. Envir. Microbiol., November 1, 2009; 75(21): 6850 - 6855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Venkatesh, L. Rong, I. Raad, and J. Versalovic Novel synergistic antibiofilm combinations for salvage of infected catheters J. Med. Microbiol., July 1, 2009; 58(7): 936 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. LiPuma, S. Rathinavelu, B. K. Foster, J. C. Keoleian, P. E. Makidon, L. M. Kalikin, and J. R. Baker Jr. In Vitro Activities of a Novel Nanoemulsion against Burkholderia and Other Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species Antimicrob. Agents Chemother., January 1, 2009; 53(1): 249 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Flemming, C. Klingenberg, J. P. Cavanagh, M. Sletteng, W. Stensen, J. S. Svendsen, and T. Flaegstad High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms J. Antimicrob. Chemother., January 1, 2009; 63(1): 136 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Venkatesh and L. Rong Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis J. Med. Microbiol., September 1, 2008; 57(9): 1113 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Smith and I. S. Hunter Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates J. Med. Microbiol., August 1, 2008; 57(8): 966 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gualtieri, L. Bastide, P. Villain-Guillot, S. Michaux-Charachon, J. Latouche, and J.-P. Leonetti In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms J. Antimicrob. Chemother., October 1, 2006; 58(4): 778 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cerca, K. K. Jefferson, R. Oliveira, G. B. Pier, and J. Azeredo Comparative Antibody-Mediated Phagocytosis of Staphylococcus epidermidis Cells Grown in a Biofilm or in the Planktonic State. Infect. Immun., August 1, 2006; 74(8): 4849 - 4855. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cerca, S. Martins, S. Sillankorva, K. K. Jefferson, G. B. Pier, R. Oliveira, and J. Azeredo Effects of Growth in the Presence of Subinhibitory Concentrations of Dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus Biofilms Appl. Envir. Microbiol., December 1, 2005; 71(12): 8677 - 8682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Moskowitz, J. M. Foster, J. C. Emerson, R. L. Gibson, and J. L. Burns Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection J. Antimicrob. Chemother., November 1, 2005; 56(5): 879 - 886. [Abstract] [Full Text] [PDF] |
||||




